Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: heltzen (2)
heltzen
investor
nutraceuticals
medicine
press clippings
video
NCT
cannabinoids
'The Upside' interview: Michael Heltzen & Lou Basenese
November 18, 2025
heltzen
investor
press clippings
video
Jane King interviews CEO, Michael Heltzen, in New York
November 12, 2025
heltzen
investor
CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference
October 30, 2025
heltzen
investor
CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor Conference
October 29, 2025
heltzen
investor
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference
October 23, 2025
heltzen
press clippings
video
podcast
Podcast: 'The Catalyst' interviews CEO, Michael Heltzen
October 17, 2025
heltzen
press clippings
video
podcast
Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen
October 2, 2025
heltzen
investor
press clippings
video
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic
September 18, 2025
heltzen
press release
investor
nutraceuticals
video
science
ARCHIVE
ARCHIVE: eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months
July 22, 2025
heltzen
press release
investor
press clippings
video
ARCHIVE
podcast
ARCHIVE: Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'
May 16, 2025
Previous page
Page 2 of 3
Next page